Topic: How To Invest

Dividend Advisor Hotline – Friday, November 5, 2021

Article Excerpt

PFIZER INC., $48.61, New York symbol PFE, is a top pick for 2021. The company is one of the world’s largest makers of prescription drugs. Its top-selling brands include Lyrica (epilepsy), Celebrex (arthritis pain), Prevnar (pneumonia) and Enbrel (rheumatoid arthritis). With the March 2021 payment, Pfizer raised your dividend by 2.6%. Investors now receive $0.39 a share instead of $0.38. The new annual rate of $1.56 yields a solid 3.2%. The stock jumped 11% on Friday after Pfizer announced that its experimental COVID-19 pill (called Paxlovid) was 89% effective at preventing people with underlying health problems from needing hospitalization or dying. That includes protection against the more contagious Delta variant. If regulators approve, the company could begin delivering Paxlovid by the end of 2021. Pfizer also continues to benefit from strong demand for its two-shot COVID-19 vaccine (formally called Comirnaty), developed in partnership with German drugmaker BioNTech (Nasdaq symbol BNTX). The U.S. Centers for Disease Control and Prevention have now approved the Comirnaty vaccine for children…